相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis
Hong You et al.
HEPATOLOGY INTERNATIONAL (2022)
Primary biliary cholangitis: 2021 practice guidance update from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2022)
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome
Cumali Efe et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)
Fibrates for Itch (FITCH) in Fibrosing Cholangiopathies: A Double-Blind, Randomized, Placebo-Controlled Trial
Elsemieke de Vries et al.
GASTROENTEROLOGY (2021)
Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis
Karim T. Osman et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)
Anxiety and Depression in Patients with Primary Biliary Cholangitis: Current Insights and Impact on Quality of Life
Tarika Sivakumar et al.
HEPATIC MEDICINE-EVIDENCE AND RESEARCH (2021)
Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)
Primary biliary cholangitis with normal alkaline phosphatase: A neglected clinical entity challenging current guidelines
Benedetta Terziroli Beretta-Piccoli et al.
JOURNAL OF AUTOIMMUNITY (2021)
Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis
Yukihisa Fujinaga et al.
MEDICINE (2021)
Safety of fibrates in cholestatic liver diseases
Andres F. Carrion et al.
LIVER INTERNATIONAL (2021)
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach
Laura Cristoferi et al.
HEPATOLOGY (2021)
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis-2021 update
Annalisa Berzigotti et al.
JOURNAL OF HEPATOLOGY (2021)
Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis
Emanuel K. Manesis et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2021)
Combination of fibrates with obeticholic acid is able to normalise biochemical liver tests in patients with difficult-to-treat primary biliary cholangitis
Pierre-Antoine Soret et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Real-world experience with obeticholic acid in patients with primary biliary cholangitis
Daphne D'Amato et al.
JHEP REPORTS (2021)
Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis
Nikolaos K. Gatselis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase
Carla F. Murillo Perez et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis
F. Nevens et al.
DIGESTIVE AND LIVER DISEASE (2020)
Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
Satoru Joshita et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Fenofibrate Improves Liver Function and Reduces the Toxicity of the Bile Acid Pool in Patients With Primary Biliary Cholangitis and Primary Sclerosing Cholangitis Who Are Partial Responders to Ursodiol
Nisanne S. Ghonem et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2020)
Canal of Hering loss is an initiating step for primary biliary cholangitis (PBC): A hypothesis
Neil D. Theise et al.
MEDICAL HYPOTHESES (2020)
Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases
Keith D. Lindor et al.
HEPATOLOGY (2019)
Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy
C. L. Bowlus et al.
DIGESTIVE AND LIVER DISEASE (2019)
Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
Chunyan Sun et al.
JOURNAL OF AUTOIMMUNITY (2019)
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
Jiang-Hua Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study
Kristjan T. Ornolfsson et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
Cumali Efe et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury et al.
JOURNAL OF HEPATOLOGY (2019)
Additional fibrate treatment in UDCA-refractory PBC patients
Sung Won Chung et al.
LIVER INTERNATIONAL (2019)
Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study
Michael Trauner et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response
Carla F. Murillo Perez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)
Diagnosis and Management of Primary Biliary Cholangitis
Zobair M. Younossi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
Mei Lu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems
Mei Lu et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural history
Carla F. Murillo Perez et al.
HEPATOLOGY (2018)
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis
C. Corpechot et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis
Gideon M. Hirschfield et al.
JOURNAL OF HEPATOLOGY (2017)
Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy
Willem J. Lammers et al.
GASTROENTEROLOGY (2015)
Fenofibrate is effective adjunctive therapy in the treatment of primary biliary cirrhosis: A meta-analysis
Alla Y. Grigorian et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
Willem J. Lammers et al.
GASTROENTEROLOGY (2014)
Early Biochemical Response to Ursodeoxycholic Acid and Long-Term Prognosis of Primary Biliary Cirrhosis: Results of a 14-Year Cohort Study
Li-Na Zhang et al.
HEPATOLOGY (2013)
Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
Christophe Corpechot et al.
HEPATOLOGY (2012)
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
Kirsten Boonstra et al.
JOURNAL OF HEPATOLOGY (2012)
Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
Edith M. M. Kuiper et al.
GASTROENTEROLOGY (2009)
Prediction of Clinical Outcomes in Primary Biliary Cirrhosis by Serum Enhanced Liver Fibrosis Assay
Marlyn J. Mayo et al.
HEPATOLOGY (2008)
Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis
E. Gomez-Dominguez et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2008)
Medical progress: Primary biliary cirrhosis
MM Kaplan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Molecular mimicry of mitochondrial and nuclear autoantigens in primary biliary cirrhosis
S Shimoda et al.
GASTROENTEROLOGY (2003)
Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years
M Prince et al.
GASTROENTEROLOGY (2002)
分享论文
